Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
decrease ros » increased ros (Expand Search), decreased mor (Expand Search), decrease rice (Expand Search)
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
decrease ros » increased ros (Expand Search), decreased mor (Expand Search), decrease rice (Expand Search)
-
101
-
102
Data Sheet 1_Case Report: A case of first-line treatment for rare ROS1 fusion mutation lung adenocarcinoma with entrectinib.pdf
Published 2025“…At least 55 partner genes have been identified that can fuse with ROS1.Herein, we report a case of a lung adenocarcinoma patient harboring a rare ROS1 fusion mutation with brain metastasis, who achieved good control of both lung and intracranial lesions after treatment with Entrectinib. …”
-
103
-
104
-
105
-
106
Significant change in self-reported behaviour between Pre-Test (T1) to Follow-Up (T3).
Published 2019“…Significant decrease in the number of sweets consumed per day was identified. c) Instances of tobacco use reported at T1 and T3. …”
-
107
-
108
Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report
Published 2024“…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
-
109
-
110
-
111
-
112
-
113
-
114
Activities reported to impact SWB the most the past four weeks and Yesterday’s Activities.
Published 2022Subjects: -
115
An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals
Published 2019“…., as a radical scavenger) but unexpectedly decreases mitochondrial reactive oxygen species (ROS/H<sub>2</sub>O<sub>2</sub>) production by acting as a specific inhibitor of ROS production at the I<sub>Q</sub> site of complex I of the mitochondrial respiratory chain. …”
-
116
-
117
-
118
-
119
-
120